Parnassia Groep B.V.
- Address
- lock Available on a paid plan
Psychiatry and Psychology - Mental Disorders
The Brijder - Den Haag unit of Parnassia Groep B.V. conducts focused research on severe mental health conditions. Current studies assess innovative approaches for treatment‑resistant depression and for managing cocaine use disorder, aiming to improve long‑term outcomes and quality of life for patients.
- Non‑psychotic therapy‑resistant unipolar depression
- Cocaine use disorder in individuals receiving opioid agonist treatment
Trials explore the effectiveness of oral esketamine compared with traditional electroconvulsive therapy, as well as the potential of sustained‑release dexamphetamine to support abstinence. The site’s multidisciplinary team collaborates closely with participants to advance therapeutic options in mental health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Parnassia Groep B.V.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Parnassia Groep B.V.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy of Oral Esketamine Versus Electroconvulsive Therapy in Non-Psychotic Treatment-Resistant Unipolar Depression | Universitair Medisch Centrum Groningen | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dexamfetamine Sulfate | 1 | Unknown | 2026-03-12 | 2026-03-12 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.